Literature DB >> 31248690

Ultraviolet light induces increased T cell activation in lupus-prone mice via type I IFN-dependent inhibition of T regulatory cells.

Sonya J Wolf1, Shannon N Estadt1, Jonathan Theros2, Tyson Moore2, Jason Ellis3, Jianhua Liu2, Tamra J Reed2, Chaim O Jacob4, Johann E Gudjonsson5, J Michelle Kahlenberg6.   

Abstract

Ultraviolet (UV) light is a known trigger of skin and possibly systemic inflammation in systemic lupus erythematosus (SLE) patients. Although type I interferons (IFN) are upregulated in SLE skin after UV exposure, the mechanisms to explain increased UVB-induced inflammation remain unclear. This paper compares the role of type I IFNs in regulating immune cell activation between wild-type and lupus-prone mice following UVB exposure. 10-week old female lupus-prone (NZM2328), wild-type (BALB/c) and iNZM mice (lack a functional type I IFN receptor on NZM2328 background) were treated on their dorsal skin with 100 mJ/cm2 of UVB for 5 consecutive days. Following UVB treatment, draining lymph node cell populations were characterized via flow cytometry and suppression assays; treated skin was examined for changes in expression of type I IFN genes. Only NZM2328 mice showed an increase in T cell numbers and activation 2 weeks post UVB exposure. This was preceded by a significant increase in UVB-induced type I IFN expression in NZM2328 mice compared to BALB/c mice. Following UVB exposure, both BALB/c and iNZM mice demonstrated an increase in functional T regulatory (TReg) cells; however, this was not seen in NZM2328 mice. These data suggest a skewed UVB-mediated T cell response in lupus-prone mice where activation of T cells is enhanced secondary to a type I IFN-dependent suppression of TReg cells. Thus, we propose type I IFNs are important for UVB-induced inflammation in lupus-prone mice and may be an effective target for prevention of UVB-mediated flares.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Interferon; Systemic lupus; T cells; T(REGs); Ultraviolet light

Mesh:

Substances:

Year:  2019        PMID: 31248690      PMCID: PMC6708464          DOI: 10.1016/j.jaut.2019.06.002

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  39 in total

Review 1.  Mechanisms involved in ultraviolet light-induced immunosuppression.

Authors:  François Aubin
Journal:  Eur J Dermatol       Date:  2003 Nov-Dec       Impact factor: 3.328

2.  Plasmacytoid dendritic cells (natural interferon- alpha/beta-producing cells) accumulate in cutaneous lupus erythematosus lesions.

Authors:  L Farkas; K Beiske; F Lund-Johansen; P Brandtzaeg; F L Jahnsen
Journal:  Am J Pathol       Date:  2001-07       Impact factor: 4.307

3.  Peripheral neuropathy in systemic lupus erythematosus: pathomorphological features and distribution pattern of matrix metalloproteinases.

Authors:  Christian Mawrin; Anna Brunn; Christoph Röcken; J Michael Schröder
Journal:  Acta Neuropathol       Date:  2002-12-21       Impact factor: 17.088

4.  Phototesting in lupus erythematosus tumidus--review of 60 patients.

Authors:  A Kuhn; M Sonntag; D Richter-Hintz; C Oslislo; M Megahed; T Ruzicka; P Lehmann
Journal:  Photochem Photobiol       Date:  2001-05       Impact factor: 3.421

5.  Increased expression of Ifi202, an IFN-activatable gene, in B6.Nba2 lupus susceptible mice inhibits p53-mediated apoptosis.

Authors:  Hong Xin; Sanjay D'Souza; Trine N Jørgensen; Andrew T Vaughan; Peter Lengyel; Brian L Kotzin; Divaker Choubey
Journal:  J Immunol       Date:  2006-05-15       Impact factor: 5.422

6.  Increased apoptotic neutrophils and macrophages and impaired macrophage phagocytic clearance of apoptotic neutrophils in systemic lupus erythematosus.

Authors:  Yi Ren; Jinling Tang; M Y Mok; Albert W K Chan; Adrian Wu; C S Lau
Journal:  Arthritis Rheum       Date:  2003-10

Review 7.  Photosensitivity in patients with lupus erythematosus: a clinical and photobiological study of 100 patients using a prolonged phototest protocol.

Authors:  C J G Sanders; H Van Weelden; G A A Kazzaz; V Sigurdsson; J Toonstra; C A F M Bruijnzeel-Koomen
Journal:  Br J Dermatol       Date:  2003-07       Impact factor: 9.302

8.  Ultraviolet radiation-induced regulatory T cells not only inhibit the induction but can suppress the effector phase of contact hypersensitivity.

Authors:  Agatha Schwarz; Akira Maeda; Martin K Wild; Kerstin Kernebeck; Nicole Gross; Yoshinori Aragane; Stefan Beissert; Dietmar Vestweber; Thomas Schwarz
Journal:  J Immunol       Date:  2004-01-15       Impact factor: 5.422

Review 9.  Pathogenesis of kidney disease in systemic lupus erythematosus.

Authors:  Harini Bagavant; Shu Man Fu
Journal:  Curr Opin Rheumatol       Date:  2009-09       Impact factor: 5.006

Review 10.  Photosensitivity in cutaneous lupus erythematosus: lessons from mice and men.

Authors:  Fukumi Furukawa
Journal:  J Dermatol Sci       Date:  2003-11       Impact factor: 4.563

View more
  20 in total

1.  β-Nicotinamide Mononucleotide (NMN) Administrated by Intraperitoneal Injection Mediates Protection Against UVB-Induced Skin Damage in Mice.

Authors:  Xianrong Zhou; Hang-Hang Du; Xingyao Long; Yanni Pan; Jian Hu; Jianjun Yu; Xin Zhao
Journal:  J Inflamm Res       Date:  2021-10-07

2.  Nonlesional lupus skin contributes to inflammatory education of myeloid cells and primes for cutaneous inflammation.

Authors:  Allison C Billi; Feiyang Ma; Olesya Plazyo; Mehrnaz Gharaee-Kermani; Rachael Wasikowski; Grace A Hile; Xianying Xing; Christine M Yee; Syed M Rizvi; Mitra P Maz; Celine C Berthier; Fei Wen; Lam C Tsoi; Matteo Pellegrini; Robert L Modlin; Johann E Gudjonsson; J Michelle Kahlenberg
Journal:  Sci Transl Med       Date:  2022-04-27       Impact factor: 19.319

Review 3.  Understanding the Concept of Pre-Clinical Autoimmunity: Prediction and Prevention of Systemic Lupus Erythematosus: Identifying Risk Factors and Developing Strategies Against Disease Development.

Authors:  May Y Choi; Karen H Costenbader
Journal:  Front Immunol       Date:  2022-06-03       Impact factor: 8.786

Review 4.  Type I interferon in the pathogenesis of systemic lupus erythematosus.

Authors:  Mariana Postal; Jessica F Vivaldo; Ruth Fernandez-Ruiz; Jacqueline L Paredes; Simone Appenzeller; Timothy B Niewold
Journal:  Curr Opin Immunol       Date:  2020-11-24       Impact factor: 7.486

Review 5.  Cutaneous and systemic connections in lupus.

Authors:  Mitra P Maz; J Michelle Kahlenberg
Journal:  Curr Opin Rheumatol       Date:  2020-11       Impact factor: 4.941

6.  The early local and systemic Type I interferon responses to ultraviolet B light exposure are cGAS dependent.

Authors:  Sladjana Skopelja-Gardner; Jie An; Joyce Tai; Lena Tanaka; Xizhang Sun; Payton Hermanson; Rebecca Baum; Masaoki Kawasumi; Richard Green; Michael Gale; Andrea Kalus; Victoria P Werth; Keith B Elkon
Journal:  Sci Rep       Date:  2020-05-13       Impact factor: 4.379

Review 7.  The Role of Cutaneous Type I IFNs in Autoimmune and Autoinflammatory Diseases.

Authors:  Jessica L Turnier; J Michelle Kahlenberg
Journal:  J Immunol       Date:  2020-12-01       Impact factor: 5.422

Review 8.  Lupus animal models and neuropsychiatric implications.

Authors:  Thaís Evelyn Karnopp; Gustavo Flores Chapacais; Eduarda Correa Freitas; Odirlei André Monticielo
Journal:  Clin Rheumatol       Date:  2020-11-06       Impact factor: 2.980

9.  IFN-κ Is a Rheostat for Development of Psoriasiform Inflammation.

Authors:  Mehrnaz Gharaee-Kermani; Shannon N Estadt; Lam C Tsoi; Sonya J Wolf-Fortune; Jianhua Liu; Xianying Xing; Jonathon Theros; Tamra J Reed; Lori Lowe; Dennis Gruszka; Nicole L Ward; Johann E Gudjonsson; J Michelle Kahlenberg
Journal:  J Invest Dermatol       Date:  2021-08-05       Impact factor: 8.551

Review 10.  Immune Cell-Stromal Circuitry in Lupus Photosensitivity.

Authors:  Ji Hyun Sim; William G Ambler; Isabel F Sollohub; Mir J Howlader; Thomas M Li; Henry J Lee; Theresa T Lu
Journal:  J Immunol       Date:  2021-01-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.